Cabozantinib impurity 1DYH

Product Name: Cabozantinib impurity 1DYH
CAS No.: 1621681-63-7
Chemical Name: Cabozantinib impurity 1DYH
Synonyms: Cabozantinib Impurity 04;Cabozantinib impurity 1DYH;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-6,7-dimethoxyquinolin-4-amine;4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide ;N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
CBNumber: CB15581295
Molecular Formula: C28H24FN3O6
Formula Weight: 517.51
MOL File: 1621681-63-7.mol

More

Less

Cabozantinib impurity 1DYH Property

Density: 1.36±0.1 g/cm3(Predicted)
pka: 13.86±0.70(Predicted)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

TRC

Product number: C051600
Product name: CabozantinibN-oxide
Packaging: 10mg
Price: $545
Updated: 2021/12/16

More

Less

Cabozantinib impurity 1DYH Chemical Properties,Usage,Production

Uses

Cabozantinib N-oxide is a impurity of Cabozantinib (X745500), a medication used to treat medullary thyroid cancer. As well, it can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor.

Cabozantinib impurity 1DYH Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Cabozantinib impurity 1DYH Suppliers

China 23 India 3 Global 26

1621681-63-7, Cabozantinib impurity 1DYHRelated Search:

Cabozantinib Impurity EXA 1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid Cyclopropanecarboxylic acid, 1-[[[4-[[7-methoxy-6-(sulfooxy)-4-quinolinyl]oxy]phenyl]amino]carbonyl]- 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl- Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- Cabozantinib Malate 1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]- Sunitinib Lapatinib Cabozantinib LOXO-101 Dasatinib Cabozantinib Impurity DM 1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl- N,N'-Bis(4-hydroxyphenyl)hydrazine Cabozantinib impurity DX2

N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

Cabozantinib impurity 1DYH

1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-

4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide

N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-6,7-dimethoxyquinolin-4-amine

Cabozantinib Impurity 04

1621681-63-7

C28H24FN3O6